Reversion of P-Glycoprotein-Mediated Multidrug Resistance in Human Leukemic Cell Line by Diallyl Trisulfide
Qing Xia(Nankai University), Hao Li(Qilu Hospital of Shandong University), Xiaoli Li(Fujian Medical University), Zhiyong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xueliang Chen(Qilu Hospital of Shandong University), Huiqing Li(Kunming University of Science and Technology), Jia Cui(Xijing Hospital), Yutao Diao(Shandong First Medical University)
Cited by 20
Related Papers
Roles of circRNAs in the tumour microenvironment
|Molecular Cancer|2020|281
The Physiologic Role of CD19 Cytoplasmic Tyrosines
|Immunity|2002|145
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
|Journal of Experimental & Clinical Cancer Research|2020|139
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
|Current Pharmaceutical Design|2017|132
Sirt3 modulate renal ischemia‐reperfusion injury through enhancing mitochondrial fusion and activating the ERK‐OPA1 signaling pathway
|Journal of Cellular Physiology|2019|115